EcoDrugPlus

Matrix Metallopeptidase 9

Ensembl ID : ENSOMYG00000009763
Gene Symbol: MMP9
1 Cross references
209 Possible Orthologues:

Matrix Metalloproteinase 9

Ensembl ID : ENSOMYG00000057861
Gene Symbol: MMP9
2 Cross references
209 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSOMYG00000035019
Gene Symbol: MTOR
1 Cross references
217 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSOMYG00000026295
Gene Symbol: MC1R
3 Cross references
154 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSOMYG00000041033
Gene Symbol: MC1R
1 Cross references
155 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSOMYG00000005068
Gene Symbol: MC3R
1 Cross references
133 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSOMYG00000065974
Gene Symbol: MC3R
1 Cross references
133 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSOMYG00000045854
Gene Symbol: MC4R
1 Cross references
24 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSOMYG00000030554
Gene Symbol: MC4R
1 Cross references
76 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSOMYG00000010233
Gene Symbol: MC4R
1 Cross references
24 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSOMYG00000012402
Gene Symbol: MC4R
1 Cross references
76 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSOMYG00000041841
Gene Symbol: MTNR1A
1 Cross references
136 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).